Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Lipocine (LPCN) Return on Invested Capital (2016 - 2025)

Lipocine's Return on Invested Capital history spans 12 years, with the latest figure at 0.33% for Q3 2025.

  • For Q3 2025, Return on Invested Capital fell 79.0% year-over-year to 0.33%; the TTM value through Sep 2025 reached 0.33%, down 79.0%, while the annual FY2024 figure was 0.0%, 12.0% up from the prior year.
  • Return on Invested Capital reached 0.33% in Q3 2025 per LPCN's latest filing, down from 0.24% in the prior quarter.
  • In the past five years, Return on Invested Capital ranged from a high of 0.46% in Q3 2024 to a low of 0.7% in Q3 2023.
  • Average Return on Invested Capital over 5 years is 0.17%, with a median of 0.24% recorded in 2025.
  • Peak YoY movement for Return on Invested Capital: skyrocketed 116bps in 2024, then plummeted -79bps in 2025.
  • A 5-year view of Return on Invested Capital shows it stood at 0.0% in 2021, then plummeted by -10148bps to 0.33% in 2022, then soared by 52bps to 0.16% in 2023, then soared by 100bps to 0.0% in 2024, then crashed by -377006bps to 0.33% in 2025.
  • Per Business Quant, the three most recent readings for LPCN's Return on Invested Capital are 0.33% (Q3 2025), 0.24% (Q2 2025), and 0.26% (Q1 2025).